Peptic Ulcer Bleeding – Comprehensive Medical Guide
Overview
Peptic ulcer bleeding (PUB) occurs when an ulcer—an open sore in the lining of the stomach, duodenum (the first part of the small intestine), or, less commonly, the esophagus—erodes into a blood vessel, causing acute or chronic hemorrhage. It is one of the most common causes of emergency gastrointestinal (GI) bleeding worldwide.
Who it affects: PUB can affect anyone, but the highest incidence is seen in adults 50‑70 years old, particularly men. According to the World Health Organization, peptic ulcer disease (PUD) affects roughly 5‑10 % of the global population, and about 10‑20 % of those with PUD will experience a bleeding episode during their lifetime.[1][2]
Prevalence: In the United States, approximately 300,000 hospital admissions each year are due to upper‑GI bleeding, and peptic ulcers account for 50‑70 % of these cases.[3] Mortality has fallen dramatically with modern therapy (now < 5 % in most series), but the condition still accounts for an estimated 30,000 deaths annually worldwide.[4]
Symptoms
Bleeding can be sudden (massive arterial bleed) or slow (occult). Recognizing the full spectrum of symptoms helps prompt diagnosis.
- Hematemesis: Bright red or coffee‑ground‑colored vomit indicating fresh or partially digested blood.
- Melena: Black, tarry stools caused by digested blood; may be accompanied by a distinct “fecal odor.”
- Occult blood loss: Positive stool guaiac test without visible blood; often presents as iron‑deficiency anemia.
- Fatigue, weakness, or light‑headedness: Result of blood loss and anemia.
- Dizziness or syncope: Especially when standing (orthostatic hypotension).
- Abdominal pain: Typically a gnawing or burning epigastric pain that may worsen after meals.
- Rapid heartbeat (tachycardia): Compensatory response to hypovolemia.
- Shortness of breath: Can occur with significant anemia.
- Feeling “cold” or pale skin: Signs of reduced perfusion.
Causes and Risk Factors
Primary causes
- Helicobacter pylori infection: The bacterium damages the mucosal barrier, leading to ulcer formation and subsequent erosion into vessels.[5]
- Non‑steroidal anti‑inflammatory drugs (NSAIDs): Inhibit prostaglandin synthesis, weakening the gastric mucus layer.[6]
- Aspirin and antiplatelet agents: Impair platelet aggregation, increasing the risk of hemorrhage from a pre‑existing ulcer.
- Stress‑related mucosal disease: Severe physiologic stress (e.g., major surgery, trauma, sepsis) can cause acute erosive gastritis that bleeds.
- Other ulcerogenic drugs: Steroids (when combined with NSAIDs), anticoagulants (warfarin, DOACs), and selective serotonin reuptake inhibitors (SSRIs) raise bleeding risk.
Risk factors that heighten the chance of bleeding
- Age > 60 years
- History of previous ulcer or ulcer bleeding
- Chronic kidney disease or liver cirrhosis
- Heavy alcohol consumption
- Smoking (increases H. pylori colonization and impairs mucosal defenses)
- High‑dose or long‑term NSAID use
- Concurrent use of anticoagulants or antiplatelet drugs
- Severe comorbidities (e.g., heart failure, COPD)
Diagnosis
Prompt diagnosis is essential because bleeding can become life‑threatening within hours.
Initial clinical assessment
- Vital signs: blood pressure, heart rate, respiratory rate, oxygen saturation.
- Physical exam: look for pallor, orthostatic changes, abdominal tenderness.
- Laboratory tests:
- Complete blood count (CBC) – assesses hemoglobin/hematocrit.
- Basic metabolic panel – evaluates electrolytes, renal function.
- Coagulation profile (PT/INR, aPTT) – especially if on anticoagulants.
- Stool guaiac test – detects occult blood.
Endoscopic evaluation
Upper gastrointestinal endoscopy (esophagogastroduodenoscopy, EGD) is the gold standard. Performed within 24 hours of presentation, it allows direct visualization, grading of bleeding stigmata (active spurting, oozing, non‑bleeding visible vessel, adherent clot, pigmented spot), and therapeutic intervention (see Treatment section).[7]
Imaging studies (when endoscopy is not feasible)
- CT angiography: Detects active extravasation and can guide interventional radiology.
- Radionuclide (99mTc‑labeled) bleeding scan: Sensitive for low‑rate bleeds but less specific.
- Mesenteric angiography: Both diagnostic and therapeutic; allows selective embolisation of bleeding vessels.
Treatment Options
Management is two‑pronged: stabilize the patient, then control the source of bleeding, followed by maintenance therapy to prevent recurrence.
Initial stabilization
- Airway protection if vomiting large amounts of blood.
- Intravenous (IV) large‑bore access (two lines).
- Fluid resuscitation with isotonic crystalloids; transfuse packed red blood cells if hemoglobin < 7 g/dL (or higher threshold in cardiac disease).[8]
- Stop all anticoagulant/antiplatelet drugs (except low‑dose aspirin when cardiovascular risk is high—decision made with cardiology).
- IV proton pump inhibitor (PPI) bolus (e.g., 80 mg pantoprazole) followed by continuous infusion (8 mg/h) to raise gastric pH > 6, stabilizing clots and enhancing endoscopic therapy efficacy.[9]
Endoscopic therapy (first‑line hemostasis)
Performed during the diagnostic EGD.
- Thermal coagulation: Heater probe or bipolar coagulation.
- Injection therapy: Epinephrine (diluted 1:10,000) – provides temporary vasoconstriction; usually combined with a second modality.
- Mechanical clipping: Hemostatic clips applied to visible vessels; highly effective for arterial bleeds.
- Topical hemostatic spray: Newer agents (e.g., Hemospray) create a protective barrier.
When endoscopy fails
- Trans‑arterial embolisation (TAE): Interventional radiology selectively blocks the bleeding artery.
- Surgical intervention: Reserved for refractory cases; may involve oversewing the ulcer, vagotomy, or partial gastrectomy.
Medical therapy for ulcer healing & recurrence prevention
- High‑dose PPIs: Oral omeprazole 20–40 mg twice daily or equivalent for 4–8 weeks.
- H. pylori eradication: Triple therapy (PPI + clarithromycin + amoxicillin/metronidazole) for 14 days; quadruple therapy if resistance suspected.[5]
- NSAID avoidance: Switch to acetaminophen or COX‑2 selective agents with gastroprotection if NSAIDs are unavoidable.
- Low‑dose aspirin: Continue only if cardiovascular benefit outweighs GI risk; add a PPI for protection.
- Helicobacter‑negative gastric ulcer follow‑up: Repeat endoscopy after 8‑12 weeks to confirm healing.
Living with Peptic Ulcer Bleeding
Daily management tips
- Medication adherence: Take PPIs exactly as prescribed; complete the full H. pylori course.
- Dietary adjustments:
- Avoid spicy, acidic, and fried foods that can irritate the ulcer.
- Eat smaller, more frequent meals rather than large meals.
- Limit caffeine and carbonated beverages.
- Alcohol & smoking: Abstain or limit alcohol; quit smoking—both impede ulcer healing.
- Monitor for anemia: Look for persistent fatigue, paleness, or shortness of breath; schedule routine CBCs as directed.
- Stress management: Practice relaxation techniques (deep breathing, yoga, mindfulness) since stress can exacerbate acid production.
- Medication review: Keep an up‑to‑date list of all drugs (prescription, OTC, supplements) and share it with every health‑care provider.
- Follow‑up appointments: Attend all endoscopy and gastroenterology visits; ask about “test‑of‑cure” for H. pylori.
Prevention
- Eradicate H. pylori: Test (urea breath test, stool antigen, or biopsy) and treat promptly.
- Use NSAIDs wisely: Take the lowest effective dose, limit duration, and always co‑prescribe a PPI or H2‑blocker.
- Vaccinate against Helicobacter (in research phase): Keep informed about emerging preventive strategies.
- Maintain a healthy weight: Obesity may increase gastric acid secretion.
- Limit alcohol intake: No more than one standard drink per day for women, two for men.
- Quit smoking: Seek cessation programs, nicotine replacement, or medications.
- Regular medical review: Elderly patients on chronic NSAIDs or anticoagulants should have periodic gastric evaluation.
Complications
If bleeding is not controlled, several serious complications can arise:
- Hemorrhagic shock: Severe blood loss leads to organ hypoperfusion, multi‑organ failure, and death.
- Re‑bleeding: Occurs in up to 20 % of cases within 72 hours; associated with higher mortality.
- Peptic stricture: Healing scar tissue can narrow the gastric outlet or duodenum, causing obstruction.
- Perforation: Ulcer penetrates full thickness of the wall, leading to peritonitis.
- Anemia: Chronic occult bleeding may cause iron‑deficiency anemia, fatigue, and reduced quality of life.
- Infection: Blood loss and transfusions can predispose to sepsis, especially in immunocompromised patients.
When to Seek Emergency Care
Call 911 or go to the nearest emergency department if you experience any of the following:
- Vomiting bright red blood or material that looks like coffee grounds.
- Black, tarry stools that are larger than usual or accompanied by weakness.
- Sudden dizziness, fainting, or feeling light‑headed when standing.
- Rapid heartbeat (> 100 beats per minute) or low blood pressure (systolic < 90 mm Hg).
- Severe abdominal pain that does not improve or is worsening.
- Signs of shock: cold, clammy skin; confusion; rapid shallow breathing.
These symptoms may indicate a massive gastrointestinal bleed that requires immediate medical intervention.
References
- World Health Organization. Peptic Ulcer Disease Fact Sheet. 2023.
- Mayo Clinic. “Peptic ulcer disease.” Updated 2022.
- American College of Gastroenterology. “Guidelines for the Management of Acute Upper GI Bleeding.” 2021.
- Centers for Disease Control and Prevention. “Gastrointestinal Bleeding Statistics.” 2022.
- NIH National Institute of Diabetes and Digestive and Kidney Diseases. “Helicobacter pylori and Peptic Ulcer Disease.” 2024.
- Cleveland Clinic. “NSAIDs and Stomach Ulcers.” 2023.
- British Society of Gastroenterology. “Endoscopy in Acute Upper GI Bleeding.” 2020.
- Joint British Societies’ Consensus Guidelines for the Management of Upper Gastrointestinal Bleeding. 2020.
- Annals of Internal Medicine. “High‑dose Proton Pump Inhibitors in Upper GI Bleeding.” 2021.